Hikma Pharmaceuticals

Hikma Pharmaceuticals is a global pharmaceutical company that develops, manufactures, and markets a broad range of branded and non-branded generic medicines. The company generates revenue through the sale of its products across various therapeutic areas, including oncology, cardiovascular, and respiratory. Founded in 1978 in Jordan, Hikma has grown significantly through strategic acquisitions and expansions, establishing a strong presence in the US, Europe, and MENA regions. Key milestones include its IPO on the London Stock Exchange in 2005 and its acquisition of Roxane Laboratories in 2016, which bolstered its US generics business.

Recent Posts by Hikma Pharmaceuticals

1-20 of 57